浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600216 浙江医药

午间休市 09-23 11:29:54

{"stockData":{"symbol":"600216","market":"SH","secType":"STK","nameCN":"浙江医药","latestPrice":13.92,"timestamp":1758598194000,"preClose":14.4,"halted":0,"volume":15891300,"delay":0,"changeRate":-0.0333,"floatShares":961999999,"shares":961999999,"eps":1.5791,"marketStatus":"午间休市","change":-0.48,"latestTime":"09-23 11:29:54","open":14.2,"high":14.3,"low":13.9,"amount":224000000,"amplitude":0.0278,"askPrice":13.93,"askSize":7,"bidPrice":13.92,"bidSize":36,"shortable":0,"etf":0,"ttmEps":1.5791,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758603600000},"marketStatusCode":3,"adr":0,"adjPreClose":14.4,"symbolType":"stock","openAndCloseTimeList":[[1758591000000,1758598200000],[1758603600000,1758610800000]],"highLimit":15.84,"lowLimit":12.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":961637750,"isCdr":false,"pbRate":1.23,"roa":"--","peRate":8.815148,"roe":"6.13%","epsLYR":1.21,"committee":0.739977,"marketValue":13386000000,"turnoverRate":0.0165,"status":1,"floatMarketCap":13386000000},"requestUrl":"/m/hq/s/600216","defaultTab":"news","newsList":[{"id":"2569882017","title":"浙江医药(600216.SH)：国投高科拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2569882017","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569882017?lang=zh_cn&edition=full","pubTime":"2025-09-22 17:47","pubTimestamp":1758534435,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浙江医药(600216.SH)发布公告，国投高科基于自身经营发展需要,计划于公告披露之日起15个交易日后的3个月内，通过集中竞价交易方式合计减持数量不超过961.64万股，即不超过公司总股本的1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0191","600216","BK0188","BK0239"],"gpt_icon":0},{"id":"2563315538","title":"每周股票复盘：浙江医药（600216）Q2净利增28.46%，股东户数微增","url":"https://stock-news.laohu8.com/highlight/detail?id=2563315538","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563315538?lang=zh_cn&edition=full","pubTime":"2025-08-31 12:27","pubTimestamp":1756614432,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，浙江医药报收于15.66元，较上周的16.23元下跌3.51%。本周，浙江医药8月26日盘中最高价报16.45元。股本股东变化截至2025年6月30日，浙江医药股东户数为6.55万户，较3月31日增加358户，增幅0.55%。业绩披露要点浙江医药2025年中报显示，主营收入43.23亿元，同比下降1.87%；归母净利润6.73亿元，同比增长113.52%；扣非净利润6.65亿元，同比增长110.1%。公司公告汇总浙江医药第十届七次董事会于2025年8月25日以通讯方式召开，全体董事出席。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600216","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2562549756","title":"股市必读：浙江医药中报 - 第二季度单季净利润同比增长28.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562549756","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562549756?lang=zh_cn&edition=full","pubTime":"2025-08-27 01:23","pubTimestamp":1756228993,"startTime":"0","endTime":"0","summary":"业绩披露要点：浙江医药2025年中报显示，归母净利润6.73亿元，同比上升113.52%。公司公告汇总浙江医药2025年半年度报告摘要显示，总资产为14,201,909,522.50元，比上年度末增长2.95%。归属于上市公司股东的净利润为673,306,732.88元，比上年同期增长113.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700001997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216"],"gpt_icon":0},{"id":"2562223143","title":"浙江医药(600216.SH)发布半年度业绩，归母净利润6.73亿元，同比增长113.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562223143","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562223143?lang=zh_cn&edition=full","pubTime":"2025-08-25 23:09","pubTimestamp":1756134559,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浙江医药(600216.SH)披露2025年半年度报告，报告期公司实现营收43.23亿元，同比下降1.87%;归母净利润6.73亿元，同比增长113.52%;扣非净利润6.65亿元，同比增长110.10%;基本每股收益0.70元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"浙江医药(600216.SH)发布半年度业绩，归母净利润6.73亿元，同比增长113.52%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600216"],"gpt_icon":0},{"id":"2562248654","title":"浙江医药(600216)6月30日股东户数6.55万户，较上期增加0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562248654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562248654?lang=zh_cn&edition=full","pubTime":"2025-08-25 18:17","pubTimestamp":1756117065,"startTime":"0","endTime":"0","summary":"证券之星消息，近日浙江医药披露，截至2025年6月30日公司股东户数为6.55万户，较3月31日增加358.0户，增幅为0.55%。在化学制药行业个股中，浙江医药股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.27万户。从股价来看，2025年3月31日至2025年6月30日，浙江医药区间涨幅为10.21%，在此期间股东户数增加358.0户，增幅为0.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500025633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0188","BK0028","600216","BK0239"],"gpt_icon":0},{"id":"2561468821","title":"浙江医药最新公告：XC2309注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2561468821","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561468821?lang=zh_cn&edition=full","pubTime":"2025-08-21 16:59","pubTimestamp":1755766777,"startTime":"0","endTime":"0","summary":"浙江医药(600216.SH)公告称，公司收到国家药品监督管理局核准签发关于XC2309注射液的《药物临床试验批准通知书》，同意开展临床试验。XC2309注射液是一种化学药品1类注射剂，规格为5ml:10mg，临床拟用于各种情况引起的消化道溃疡出血。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100028041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600216","BK0188","BK0191","BK0239"],"gpt_icon":0},{"id":"2560978695","title":"浙江医药上周获融资净买入1613.40万元，居两市第494位","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978695","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560978695?lang=zh_cn&edition=full","pubTime":"2025-08-18 07:41","pubTimestamp":1755474076,"startTime":"0","endTime":"0","summary":"8月18日，沪深两融数据显示，浙江医药上周累计获融资净买入额1613.40万元，居两市第494位，上周融资买入额2.65亿元，偿还额2.49亿元。资金流方面，浙江医药近5日主力资金流出905.68万元，区间跌幅0.52%；近10日主力资金流出1.34亿元，区间跌幅3.43%。通过天眼查大数据分析，浙江医药股份有限公司共对外投资了28家企业，参与招投标项目83次，知识产权方面有商标信息190条，专利信息27条，此外企业还拥有行政许可46个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/18074152494425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK0191","BK0028","BK0239","600216"],"gpt_icon":0},{"id":"2560925418","title":"每周股票复盘：浙江医药（600216）完成1.9998亿元股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925418","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925418?lang=zh_cn&edition=full","pubTime":"2025-08-17 03:34","pubTimestamp":1755372853,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，浙江医药报收于15.74元，较上周的15.55元上涨1.22%。本周，浙江医药8月14日盘中最高价报15.94元。浙江医药当前最新总市值151.36亿元，在化学制药板块市值排名42/150，在两市A股市值排名1203/5152。本周关注点公司公告汇总：浙江医药完成1.9998亿元股份回购，占总股本1.43%公司公告汇总浙江医药股份有限公司完成了股份回购计划，回购股数为13723200股，占总股本1.43%，实际回购金额为199982725元，回购价格区间为13.31元/股至16.09元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600216","BK0028","BK0239","BK0191","BK0188"],"gpt_icon":0},{"id":"2558643257","title":"浙江医药：累计回购约1372万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643257","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558643257?lang=zh_cn&edition=full","pubTime":"2025-08-12 17:00","pubTimestamp":1754989206,"startTime":"0","endTime":"0","summary":"每经AI快讯，浙江医药 8月12日晚间发布公告称，2025年8月11日，公司完成回购，通过上海证券交易所系统以集中竞价方式累计回购公司股份约1372万股，占公司目前总股本的1.43%，回购最高价格为16.09元/股，最低价格为13.31元/股，回购均价为14.57元/股，使用资金总额为人民币约2亿元。2024年1至12月份，浙江医药的营业收入构成为：人类营养品占比50.1%，药品占比48.85%，其他占比0.64%，其他业务占比0.41%。截至发稿，浙江医药市值为150亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508121700579742a7d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508121700579742a7d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600216","BK0239","BK0028","BK0188","BK0191"],"gpt_icon":0},{"id":"2557514285","title":"原料药上市公司财务总监PK：40岁及以下CFO占比26% 新诺威戴龙为业内最年轻CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2557514285","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557514285?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:13","pubTimestamp":1754622780,"startTime":"0","endTime":"0","summary":"专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为81.48万元。其中，目前仍任职的最年轻的上市公司CFO年龄33岁，为新诺威的戴龙。从薪酬分布看，A股原料药公司CFO年薪平均值为66.12万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0226","600216","BK0028","BK0191","300765","605507","BK0188"],"gpt_icon":0},{"id":"2557515613","title":"青蒿素概念盘中跳水，润都股份跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515613?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:48","pubTimestamp":1754617708,"startTime":"0","endTime":"0","summary":"08月08日，青蒿素概念盘中跳水，截至09点48分，青蒿素概念整体指数下跌1.03%，报1345.260点。从个股上来看，该概念的成分股中，润都股份跌5.21%，华润双鹤、复星医药、浙江医药跌幅居前。从资金上来看，截止发稿，青蒿素概念主力净流入为-4970.75万，其中昆药集团受到资金热捧，主力净流入308.81万；拉长时间线来看，该板块近20日主力资金净流入-12.62亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094828973ac510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094828973ac510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600062","BK0028","600196","BK0010","BK0185","BK0239","002923","BK0188","600422","02196","BK0175","600216"],"gpt_icon":0},{"id":"2556489578","title":"浙江医药：新工厂进度按计划推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2556489578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556489578?lang=zh_cn&edition=full","pubTime":"2025-08-01 17:03","pubTimestamp":1754039005,"startTime":"0","endTime":"0","summary":"证券之星消息，浙江医药(600216)08月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问企业在绍兴的新工厂进度如何？以及企业多个创新药品类的进度如何？浙江医药回复：尊敬的投资者您好，公司在绍兴地区的新建工厂包括上虞昌北生物、新昌可明生物等板块，工程进度均按计划推进中。关于公司各项重大新药研发项目已经达成的重大里程碑，请参考公司相关公告，若进展触及信披义务，公司将及时在上交所官网上披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080100028625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","600216","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2556911808","title":"浙江医药：建设现代化药业集团为企业目标的企业文化体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2556911808","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556911808?lang=zh_cn&edition=full","pubTime":"2025-08-01 16:54","pubTimestamp":1754038440,"startTime":"0","endTime":"0","summary":"有投资者向浙江医药提问， 董秘你好，百度查贵司企业文化章节中有将来“国内领先，国际称强”之词。问哈你，这是吹牛皮还是将来真有可能？目前市值一百多亿，是星星之火可以燎原吗？谢谢！公司回答表示，尊敬的投资者您好，公司在大力发展企业生产的同时，不断加强企业文化建设，逐渐形成了以药业报国为己任、践行\"关爱人类健康\"的企业宗旨，大力弘扬\"团结、拼搏、创新、奉献\"的企业精神，建设\"品质标准化、管理国际化、研发原创化、资本市场化\"的现代化药业集团为企业目标的企业文化体系，形成了先进的管理制度和行为规范，达到内求团结、外求发展，激发员工积极进取，为实现浙江医药可持续发展提供了强大动力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801170904a46f6703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801170904a46f6703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0191","BK0239","600216","BK0188"],"gpt_icon":0},{"id":"2556428860","title":"浙江医药：累计回购1.19%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2556428860","media":"格隆汇资讯","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556428860?lang=zh_cn&edition=full","pubTime":"2025-08-01 15:47","pubTimestamp":1754034478,"startTime":"0","endTime":"0","summary":"格隆汇8月1日丨浙江医药(600216.SH)公布，截至2025年7月31日，公司通过集中竞价交易方式累计回购股份11,412,800股，已回购股份占公司总股本的比例为1.19%，成交的最高价为15.30元/股，最低价为13.31元/股，已支付的总金额为163,769,877元（不含交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801154805972c529d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801154805972c529d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","BK0028","600216","BK0188"],"gpt_icon":0},{"id":"2556694558","title":"原料药上市公司董秘PK：赛分科技王中蕾任董秘不足一年 年仅30岁已收获超150万年薪","url":"https://stock-news.laohu8.com/highlight/detail?id=2556694558","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556694558?lang=zh_cn&edition=full","pubTime":"2025-08-01 12:57","pubTimestamp":1754024241,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股董秘数据报告》显示，2024年A股上市公司董秘薪酬合计达40.86亿元，平均年薪75.43万元。其中，最年轻的上市公司董秘年仅30岁，为赛分科技的王中蕾。从董秘的学历分布看，本科学历董秘超过半数。从薪酬分布看，A股原料药上市公司董秘年薪平均值为60.84万元。从任职年限看，五位最高薪董秘分别于公司任职5年、不足1年、5年、8年、不足2年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801125730972bf774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801125730972bf774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603538","603351","600216","605177","605507","688166","BK0239","605116","688758","603229","BK0229"],"gpt_icon":0},{"id":"2555094790","title":"浙江医药涨5.37%创近7个月新高 政策调整与资金博弈共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2555094790","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555094790?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:02","pubTimestamp":1753851769,"startTime":"0","endTime":"0","summary":"浙江医药股价今日表现强势，截至13点02分，最新价报16.29元，上涨5.37%，创近7个月以来新高。资金博弈与政策扰动双向共振浙江医药近期净流入主要受政策调整与资金面博弈驱动。截至7月29日，主力资金连续两个交易日呈现净流入，累计达7347.18万元，杠杆资金近三日累计买入1.88亿元，显示短期多空博弈加剧。产业升级与全球布局重塑价值中枢浙江医药长期竞争力锚定于全球化战略与研发壁垒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730130300a6c90192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730130300a6c90192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600216","BK0188","BK0028","BK0191"],"gpt_icon":0},{"id":"2555109936","title":"维生素概念盘中拉升，尔康制药涨8.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555109936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555109936?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:15","pubTimestamp":1753845325,"startTime":"0","endTime":"0","summary":"07月30日，维生素概念盘中拉升，截至11点15分，维生素概念整体指数上涨1.02%，报1783.160点。从个股上来看，该概念的成分股中，尔康制药涨8.69%，梅花生物、浙江医药、新 和 成涨幅居前。从资金上来看，截止发稿，维生素概念主力净流入为-1.59亿，其中华润三九受到资金热捧，主力净流入5509.24万；拉长时间线来看，该板块近20日主力资金净流入-18.33亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011152594c2e836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0077","600873","BK0239","BK0191","BK0028","300267","600216"],"gpt_icon":0},{"id":"2555909347","title":"青蒿素概念盘中拉升，华润双鹤涨9.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555909347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555909347?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:41","pubTimestamp":1753839718,"startTime":"0","endTime":"0","summary":"07月30日，青蒿素概念盘中拉升，截至09点41分，青蒿素概念整体指数上涨2.05%，报1370.400点。从个股上来看，该概念的成分股中，华润双鹤涨9.73%，浙江医药、润都股份、新 和 成涨幅居前。从资金上来看，截止发稿，青蒿素概念主力净流入为9459.56万，其中华润双鹤受到资金热捧，主力净流入7812.87万；拉长时间线来看，该板块近20日主力资金净流入-6.40亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073009415894c2bab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073009415894c2bab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0175","BK0185","BK0028","BK0191","BK0239","BK0010","600216","600062"],"gpt_icon":0},{"id":"2555352200","title":"【聚焦】重庆药友制药拿下20亿注射剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2555352200","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555352200?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:13","pubTimestamp":1753776809,"startTime":"0","endTime":"0","summary":"精彩内容近日，国家药监局官网显示，重庆药友制药申报的4类仿制药注射用盐酸万古霉素获批生产并视同过评。米内网数据显示，注射用盐酸万古霉素已被纳入国家医保乙类目录，2022年以来在中国三大终端六大市场的销售额均达20亿元以上。今年以来重庆药友制药获批上市的品种来源：米内网中国申报进度数据库","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163231a6c7768c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163231a6c7768c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","600216","600789","600267","BK0188","BK0060","600812"],"gpt_icon":0},{"id":"2555088218","title":"青蒿素概念盘中跳水，润都股份跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555088218?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:36","pubTimestamp":1753753008,"startTime":"0","endTime":"0","summary":"07月29日，青蒿素概念盘中跳水，截至09点36分，青蒿素概念整体指数下跌0.70%，报1335.650点。从个股上来看，该概念的成分股中，润都股份跌0.74%，浙江医药、白云山、新 和 成跌幅居前。从资金上来看，截止发稿，青蒿素概念主力净流入为-1.11亿，其中海正药业受到资金热捧，主力净流入394.12万；拉长时间线来看，该板块近20日主力资金净流入-6.05亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093648a6c6ca96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093648a6c6ca96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","BK1606","600216","BK1515","BK1197","BK1191","600332","00874"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758598796860,"stockEarnings":[{"period":"1week","weight":-0.047},{"period":"1month","weight":-0.1128},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.0885},{"period":"1year","weight":0.0027},{"period":"ytd","weight":-0.07}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.1193},{"period":"6month","weight":0.1365},{"period":"1year","weight":0.3989},{"period":"ytd","weight":0.1423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"65531人(较上一季度增加0.55%)","perCapita":"14674股","listingDate":"1999-10-21","address":"浙江省绍兴市越城区滨海新城致远中大道168号","registeredCapital":"96163万元","survey":"　　浙江医药股份有限公司的主营业务是生命营养品、药品。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素等维生素和类维生素产品、医药制造类产品及医药商业。报告期内，公司在CPHI2025荣获“LeadingEnterpriseofPharmaInternationalizationAwards”（医药国际化领军企业奖），在HHB健康美丽产业高质量发展大会被评为“健康美丽产业绿色可持续发展先锋企业”。","listedPrice":5.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浙江医药,600216,浙江医药股票,浙江医药股票老虎,浙江医药股票老虎国际,浙江医药行情,浙江医药股票行情,浙江医药股价,浙江医药股市,浙江医药股票价格,浙江医药股票交易,浙江医药股票购买,浙江医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浙江医药(600216)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浙江医药(600216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}